Use of human Dihydroorotate Dehydrogenase (hDHODH) Inhibitors in Autoimmune Diseases and New Perspectives in Cancer Therapy

Publisher： Bentham Science Publishers

E-ISSN： 2212-3970|13|1|86-105

ISSN： 1574-8928

Source： Recent Patents on Anti-Cancer Drug Discovery, Vol.13, Iss.1, 2018-01, pp. : 86-105

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The use of aromatase inhibitors in adjuvant therapy for early breast cancer

By Jonat Walter   Hilpert Felix   Maass Nicolai  

Cancer Chemotherapy and Pharmacology, Vol. 56, Iss. 1, 2005-11 ,pp. : 32-38

Springer Publishing Company

Access to resources Recommend Favorite

Angiogenesis Inhibition: State of the Art, Forgotten Strategies and New Perspectives in Cancer Therapy

By  

Current Cancer Therapy Reviews, Vol. 5, Iss. 3, 2009-08 ,pp. : 203-216

Bentham Science Publishers

Access to resources Recommend Favorite

Radiation-induced Changes in Flavin Fluorescence of Dihydroorotate Dehydrogenase

By Saha A.   Mandal P.C.   Bhattacharyya S.N.  

International Journal of Radiation Biology, Vol. 60, Iss. 5, 1991-11 ,pp. : 769-778

Informa Healthcare

Access to resources Recommend Favorite

Hypoxia-driven immunosuppression: A new reason to use thermal therapy in the treatment of cancer?

By Lee Chen-Ting   Mace Thomas   Repasky Elizabeth A.  

International Journal of Hyperthermia, Vol. 26, Iss. 3, 2010-11 ,pp. : 232-246

Informa Healthcare

Access to resources Recommend Favorite

Histone Deacetylase Inhibitors in Cancer Therapy

By Fouladi Maryam  

Cancer Investigation, Vol. 24, Iss. 5, 2006-06 ,pp. : 521-527

Informa Healthcare

Access to resources Recommend Favorite